Formulary Search Results for: CALCIUM AND VITAMIN D
5.1.7 Some other antibacterials - View Category
Restrictions:
Fidaxomicin is restricted to use for the treatment of adults with microbiologically proven recurrence of Clostridium difficile infection (CDI) only on the advice of Consultant microbiologists or Consultants in Infectious Diseases.
Please note: this is a PROTECTED ANTIBIOTIC (see policy here) and relevant paper work should be completed.
It is non-formulary for use in adults with first episode of CDI or as empirical treatment in CDI.
6.1.1.2 Intermediate- and long-acting insulins - View Category
Restrictions:
Insulin detemir (Levemir®) is restricted to use in adults with severe/ frequent nocturnal hypoglycaemia. Not for routine use in type 2 diabetes unless patients suffers from recurrent episodes of hypoglycaemia. Restricted to initiation by clinicians, either in primary care or the acute setting, experienced in the treatment of diabetes.
6.1.2.3 Incretin mimetics - View Category
Restrictions:
Restricted to initiation by clinicians, either in primary care or the acute setting, experienced in the treatment of diabetes as part of a triple therapy in patients with inadequate glycaemic control on two oral anti-diabetic drugs.
Prescribing Notes:
- Dulaglutide is a biological medicine. Biological medicines must be prescribed and dispensed by brand name; the manufacturer advises to record the brand name and batch number after each administration.
- NHSGGC Diabetes Guidelines click here
6.1.2.3 Incretin mimetics - View Category
Restrictions:
Restricted to initiation by Consultant Diabetologists for use in patients who are uncontrolled on basal insulin analogues (glycosylated haemoglobin [HbA1c] >7.5% [59mmol/mol]) and for whom a GLP-1 receptor agonist is appropriate as an add-on intensification therapy to basal insulin to obtain glucose control.
Prescribing Notes:
- Liraglutide is a biological medicine. Biological medicines must be prescribed and dispensed by brand name; the manufacturer advises to record the brand name and batch number after each administration.
- NHSGGC Diabetes Guidelines click here
6.1.2.3 Incretin mimetics - View Category
Restrictions:
Use in the treatment of type 2 diabetes mellitus (T2DM) is restricted to initiation by clinicians, either in primary care or the acute setting, experienced in the treatment of diabetes for use in addition to other oral anti-diabetic medicines, or as an add-on to basal insulin, as an alternative glucagon-like peptide-1 receptor agonist option.
Prescribing Notes:
- Semaglutide is a biological medicine. Biological medicines must be prescribed and dispensed by brand name; the manufacturer advises to record the brand name and batch number after each administration.
- NHSGGC Diabetes Guidelines click here
6.1.2.6 Dipeptidylpeptidase-4 Inhibitors - View Category
Restrictions:
Restricted to the treatment of type 2 diabetes in adults in combination with metformin when the use of a sulfonylurea is inappropriate.
Combination preparations are further restricted to use only in those patients who have demonstrable compliance issues with the separate constituents
Prescribing Notes:
NHSGGC Diabetes Guidelines click here
6.3.2 Glucocorticoid therapy - View Category
6.5.2 Posterior pituitary hormones and antagonists - View Category
6.6.2 Bisphosphonates and other drugs affecting bone metabolism - View Category
13.9.1 Shampoo preparations - View Category
Prescribing Notes:
For use in seborrhoeic scalp conditions like dermatitis. Contains benzalkonium chloride 0.5%